Sentences with phrase «pediatric cancer researcher»

While previous studies have looked at the connections between specific defects and the risk of any cancer, or specific cancers and birth defects generally, «what's missing [are] good, population - based estimates of the risk of specific cancers and associations with specific birth defects,» says coauthor Jeremy Schraw, a postdoctoral pediatric cancer researcher at Baylor College of Medicine, during a press conference at AACR.

Those firms often fear the risk and financial burden that comes with testing new and potentially dangerous compounds in children with cancer, but the scientific rationale for moving ahead with such trials «has never been greater,» says one pediatric cancer researcher.

Not exact matches

The researchers, at St. Jude Children's Research Hospital in Memphis, Tennessee, and Washington University in St. Louis in Missouri, and led by pediatric researcher and St. Jude's CEO James Downing, hunted for dangerous genes in 1120 cancer patients under the age of 20.

Ben - Gurion University of the Negev (BGU) researchers have found that babies born from mothers who underwent fertility treatments are at increased risk of developing many types of pediatric cancers and tumors (neoplasms).

Researchers investigating pediatric low - grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer.

Researchers leading the largest genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and pediatric patients with many different types of cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors» mutations or being enrolled in clinical trials.

In a prospective study, researchers sought to determine the noninferiority of palonosetron to ondansetron in pediatric patients with cancer receiving moderate or high emetogenic chemotherapy.

Asha Pillai, M.D., a specialist in pediatric hematology - oncology, was named «Cancer Researcher of the Year» by the Woman's Cancer Association of the University of Miami at its «Dancing for a Cure» Gala.

On the heels of identifying the specific type of cell that gives rise to retinoblastoma, RPB - funded researchers at St. Jude Children's Research Hospital are solving a long - standing mystery about how the eyes of vertebrates develop and how a rare pediatric eye cancer progresses.

Overweight pediatric cancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study led by researchers at MD Anderson Children's Cancer Hoscancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study led by researchers at MD Anderson Children's Cancer HosCancer Hospital.

An international coalition of pediatric cancer physicians and researchers has developed new systems to standardize studies of neuroblastomas across the world.

We are equally pleased that Peter Cole, a highly accomplished clinician and researcher, will be leading our Pediatric Hematology / Oncology Program and helping to expand the depth and breadth of pediatric cancer treatment offerings across RWJBarnabas Health,» notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs forcancer treatment offerings across RWJBarnabas Health,» notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs forCancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs forcancer programs for RBHS.

In 2008, she led an international coalition of pediatric cancer physicians and researchers who developed new systems to standardize studies of neuroblastoma worldwide.

These initial findings have paved the way to expand the program into a more comprehensive pediatric precision oncology program that researchers expect to launch in 2016, which will include offering sequencing to pediatric cancer patients diagnosed at other hospitals.

When the researchers inserted that mutation into mice, the result was an undifferentiated pediatric sarcoma (cancer of connective tissue), as might be expected due to the arrest of the stem cell's development caused by the K36 mutation.

Long supported by grants from the National Institutes of Health, National Cancer Institute and other philanthropic entities, Cole is an active clinical researcher having developed pediatric cancer clinical trial protocols in conjunction with the national cooperative organization Children's Oncology Group and other collaborCancer Institute and other philanthropic entities, Cole is an active clinical researcher having developed pediatric cancer clinical trial protocols in conjunction with the national cooperative organization Children's Oncology Group and other collaborcancer clinical trial protocols in conjunction with the national cooperative organization Children's Oncology Group and other collaborators.

In time, the researchers hope to offer gene sequencing to most, if not all, pediatric cancer patients at Mott.